Kirill Dmitriev, head of Russia’s state-owned investment fund, said Russia will sell the Sputnik V nasal vaccine to other countries next year, according to television footage obtained by Reuters.
The Russian Direct Investment Fund (RDIF), which is responsible for the overseas sales of domestically produced vaccines in Russia, announced after President Vladimir Putin took a Sputnik booster shot last week.
Putin received his first dose of Sputnik V in April of this year and was boosted by Sputnik Light last week.
He said in a statement to state media TASS that he was asked to breathe in and was vaccinated with a syringe.
The president also told TASS that he felt good after the booster. “I was re-vaccinated two hours ago. I have no idea. I’m in normal condition. Everything is fine,” he said.
“Just 6 months after vaccination, my titer is protective [antibodies] According to Hill, Putin added.
Sputnik V is a two-shot recombinant adenovirus-based vaccine with a 3-week interval between shots and is 91.6% effective against COVID-19 in adults 18 years and older, according to a February study. Lancet..
Of the 16,427 people in the vaccine group, 45 reported serious side effects and 3 died, Lancet concluded: [the deaths] It was thought to be related to the vaccine. “
Sputnik Light, which contains the first component of Sputnik V, is a “stand-alone one-shot vaccine” that claims to be more than 80% effective against infection. Website..
As of November 18 Statista It is estimated that almost 36 percent of Russians are fully vaccinated.
According to the report, as of November 23, Russia has been vaccinated 119,759,585 times. World Health Organization (WHO), its vaccination rollout is still among the lowest in Europe.
Faced with an increasing number of COVID-19 cases in October, Putin addressed the vaccine hesitation by warning against “disease and its significant consequences.”
“I don’t understand what’s going on,” Putin said. “We have a reliable and efficient vaccine. Vaccines really reduce the risk of illness, serious complications, and death.”
According to the RDIF, the Russian Ministry of Health plans to enroll the Sputnik V vaccine for adolescents between the ages of 12 and 17.
The Sputnik V vaccine has not yet been approved by WHO after it was discovered by the inspector. Manufacturing concerns The approval process stopped in September.